Related Experiment Video

Updated: Aug 20, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Docking study of ligands into the colchicine binding site of tubulin

Amaury Farce1, Cedric Loge, Sebastien Gallet

  • 1Laboratoire de Chimie Thérapeutique, Faculté des Sciences Pharmaceutiques et Biologiques, 59006 Lille Cedex, France.

Journal of Enzyme Inhibition and Medicinal Chemistry
|January 25, 2005
PubMed

Insights

This study characterizes the binding site of colchicine, an antimitotic drug, on microtubules. Understanding this interaction is key to developing new cancer treatments that stop cell division.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer is a leading cause of death globally, necessitating novel therapeutic strategies.
  • Antimitotic drugs, such as spindle poisons, combat cancer by inhibiting mitosis.
  • Microtubules, composed of alpha and beta-tubulin heterodimers, are key targets for these drugs.

Purpose of the Study:

  • To characterize the specific binding site of colchicine on tubulin dimers.
  • To investigate the molecular interactions of colchicine with microtubules.
  • To explore potential new drug candidates targeting microtubule dynamics.

Main Methods:

  • Molecular docking simulations were employed to analyze drug-target interactions.
  • A series of reference compounds were docked to identify key binding interactions.
  • Novel ligands were designed and docked to assess their binding affinity and potential efficacy.

Main Results:

  • The study successfully mapped the binding site of colchicine within the tubulin dimer.
  • Docking analyses provided insights into the molecular mechanisms of colchicine's antimitotic activity.
  • Characterization of the binding site facilitates the design of more effective antimitotic agents.

Conclusions:

  • The precise characterization of the colchicine binding site on tubulin is crucial for understanding microtubule dynamics.
  • This research paves the way for the rational design of novel anticancer drugs targeting tubulin.
  • Targeting microtubule dynamics remains a promising strategy in cancer therapy.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...